Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUPRA: Personalized Medicine in Rheumatoid Arthritis
NCT05305066Recruiting
- Start
- Feb 2023
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Randomised trial in rheumatoid arthritis (RA) (4 arms). Primary endpoints: Rate of recruitment at two RA referral centers at 12 months, Prompt access to drugs at 4 weeks and 6 more. Started Feb 2023; status: recruiting.
02
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT05305066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05305066.